63 results found

The boundary between medicinal products and medical devices remains a recurring issue for companies developing or marketing borderline products and courts, which has already been the subject of numerous decisions.

On 6 September 2018, the German Federal Patent Court denied an application for a (preliminary) compulsory license ...

Der Anwalt Ulrich Worm, Partner im Frankfurter Büro von Mayer Brown, bezweifelt, dass Zwangslizenzen zu mehr Dosen des Corona-Impfstoffes führen würden.

The Dutch are known for making world famous cheese, among many other things! Recently, two Dutch cheese companies indulged in a legal battle over the Taste of cheese.

Once again there is a new attempt in Germany to introduce stricter requirements for food safety – despite the full harmonization approach in general EU food law.

On 4 June 2019, the German Federal Court of Justice upheld a ruling by the German Federal Patent Court in which the latter court denied an application for a compulsory license under a patent related

The CJEU has decided on a matter of great importance for applicants of pharmaceutical patents who have already obtained a supplementary protection certificate on the basis of a marketing authorization or who intend to do so.

The European Commission has made legally binding Sanofi's commitments to address preliminary competition concerns regarding alleged disparagement of a competing enhanced flu vaccine in Germany and France.

In a move to tackle the severe shortage of medicines, the German Federal Government has adopted the draft Act to Improve the Supply of Medicines and Avoid Shortages...

Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...

Dass die aktuelle Wirtschaftslage bei vielen zum Überdenken der Konsumentscheidungen führt, mag wenig überraschend sein.

Today, the CJEU has issued its much awaited decision on the classification of genome-editing tools such as CRISPR/Cas9, Talen or zinc finger within the framework of the EU's Directive 2001/18/EC...

Following the election in February, the party leaderships of CDU, CSU and SPD have agreed on a coalition agreement titled "Responsibility for Germany".

In packaging law, both European and national legislators are clearly picking up the pace. The obligation to offer reusable packaging comes into effect on 01 January 2023.

The German Federal Constitutional Court (Bundesverfassungsgericht, "BVerfG") has handed down a momentous decision for business operators selling food and feed within Germany:

Pharmaceutical advertising is regulated by the Act on Advertising in the Health Care System [HWG]. Courts regularly must decide which information about prescription drugs (Rx compounds) may also be made available to consumers and the means by which Rx compounds can be advertised

The Düsseldorf Local Division has recently issued a decision of considerable importance in the pharmaceutical field: the first decision in the UPC system dealing with second medical use claims.

On 16 August 2023, the Federal Cabinet introduced a bill on the partial legalisation of cannabis.